About the Event
Recently, research funded by The Michael J. Fox Foundation (MJFF) identified a mis-folded protein that is a biomarker for Parkinson’s Disease. This is a huge leap forward toward a treatment.
Backed by MJFF, Gain Therapeutics (NASDAQ: GANX) is deploying its SEE-Tx™ platform to develop a treatment for this devastating disease by guiding misfolded proteins back into their proper shape.
Join our webinar with Matthias Alder, Gain CEO, to learn more about this exciting breakthrough in the search for a cure for Parkinson’s.